Trial
NCT04855747
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Levomecor Inc.
Collaborators
—
Condition
Major Depressive Disorder
Intervention
REL-1017
Why stopped
Program Discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-06